8
State-of-the-Art Management of Pituitary and Neuroendocrine Disorders APRIL 16 & 17, 2010 Hotel Casa Del Mar 1910 Ocean Way Santa Monica, CA 90405

State-of-the-Art Management of Pituitary and Neuroendocrin … · 2010-02-17 · State-of-the-Art Management of Pituitary and Neuroendocrin e 405 Hilgard Avenue Disorders Office of

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: State-of-the-Art Management of Pituitary and Neuroendocrin … · 2010-02-17 · State-of-the-Art Management of Pituitary and Neuroendocrin e 405 Hilgard Avenue Disorders Office of

State-of-the-Art Management of

Pituitary and Neuroendocrine Disorders

APRIL 16 & 17, 2010

Hotel Casa Del Mar1910 Ocean WaySanta Monica, CA 90405

Page 2: State-of-the-Art Management of Pituitary and Neuroendocrin … · 2010-02-17 · State-of-the-Art Management of Pituitary and Neuroendocrin e 405 Hilgard Avenue Disorders Office of

Ronald W. Busuttil, MDProfessor and Executive Chair, Department of SurgeryChief, Division of Liver and Pancreas TransplantationDumont Chair in Transplantation Surgery

Johannes Czernin, MDProfessorDepartment of Molecular and Medical Pharmacology

James Farrell, MDAssociate Professor of MedicineDirector of Pancreaticobiliary EndoscopyDirector Endoscopic UltrasoundDivision of Digestive Diseases

Stephen Kee, MDAssociate Professor of RadiologyChief of Interventional Radiology

Dorothy Martinez, MDAssociate Clinical Professor of MedicineDivision of Endocrinology, Diabetes and Hypertension

Noriko Salamon, MDAssociate Professor of RadiologyDirector of Neuroradiology Fellowship ProgramDivision of Neuroradiology

Michael T. Selch, MDProfessorDepartment of Radiation Oncology

Ronald S. Swerdloff, MDProfessor of MedicineChief, Division of EndocrinologyHarbor-UCLA Medical Center

William H. Yong, MDAssociate Clinical Professor of PathologyBrain Tumor Translational ResourceNeuro-Oncology Program and Department of Pathology and Laboratory Medicine

Gary Hammer, MDAssociate ProfessorDepartment of Internal Medicine Division of Metabolism, Endocrinology and DiabetesDepartment of Molecular and Integrative Physiology Millie Schembechler Professor of Adrenal CancerUniversity of MichiganAnn Arbor, Michigan Laurence Katznelson, MDAssociate Professor of Medicine and NeurosurgeryMedical Director, Pituitary CenterStanford University School of MedicineStanford, California

James Yao, MDAssociate ProfessorDeputy ChairGastrointestinal Medical Oncology DepartmentM.D. Anderson Cancer CenterHouston, Texas

Marvin Bergsneider, MDProfessor and Vice-Chair UCLA Department of NeurosurgeryCo-Director, UCLA Pituitary Tumor Program

Anthony Heaney, MD, PhDAssociate Professor UCLA Division of Endocrinologyand Department of NeurosurgeryCo-Director, UCLA Pituitary Tumor Program

Michael Yeh, MDAssistant ProfessorUCLA Department of SurgeryDirector, UCLA Endocrine Surgery Program

COURSE DIRECTORS

GUEST FACULTY

UCLA FACULTY

FACULTY

Page 3: State-of-the-Art Management of Pituitary and Neuroendocrin … · 2010-02-17 · State-of-the-Art Management of Pituitary and Neuroendocrin e 405 Hilgard Avenue Disorders Office of

FRIDAY, April 16, 2010

1:00PM Welcome Anthony Heaney, Marvin Bergsneider, Michael Yeh

1:10 Establishing the Diagnosis of Cushing’s Disease: Past, Present, and Future Anthony Heaney

1:40 State-of-the-Art Imaging of Pituitary Tumors Noriko Salamon

2:10 Practical Pituitary Pathology: Diagnoses the Endocrinologist Should Know William H. Yong 2:40 The Role of Stereotactic Irradiation for the Treatment of Pituitary Tumors Michael T. Selch

3:10 Break

3:30 High-Definition Endoscopic Pituitary Tumor Surgery - A New Era Marvin Bergsneider 4:00 Treating Pituitary Failure – A Practical Approach Ronald S. Swerdloff 4:30 Controversies in the Medical Management of Acromegaly Laurence Katznelson 5:00 Panel Discussion: Q&A

5:50 Closing Remarks

6:00 Adjourn

State-of-the-Art Management of

Pituitary and

Neuroendocrine Disorders

Page 4: State-of-the-Art Management of Pituitary and Neuroendocrin … · 2010-02-17 · State-of-the-Art Management of Pituitary and Neuroendocrin e 405 Hilgard Avenue Disorders Office of

SATURDAY, April 17, 2010

7:30AM Breakfast

8:00 Introduction Anthony Heaney, Michael Yeh

8:10 Diagnostic Approach to NETs Anthony Heaney

8:40 New Age Gastroenterology Technologies in Carcinoid & Pancreatic NETs James Farrell

9:10 Molecular Imaging of Neuroendocrine Tumors Johannes Czernin 9:40 Break

10:00 Surgical Therapy & Liver Transplant for NETs Ronald W. Busuttil

10:30 Locoregional Approaches for Metastatic Endocrine Tumors Stephen Kee 11:00 Novel Therapeutics for Neuroendocrine Tumors James Yao 11:30 Panel Discussion: Q&A

12:00PM Lunch

1:00 Introduction Anthony Heaney, Michael Yeh 1:10 Differentiated Thyroid Cancer: Latest Oncologic Principles Michael Yeh

1:40 Long-Term Surveillance for Differentiated Thyroid Cancer Dorothy Martinez

2:10 Break

2:30 Minimally Invasive Parathyroid Surgery Michael Yeh

3:00 Novel Therapeutics for Adrenocortical Carcinoma Gary Hammer

3:30 Panel Discussion: Q&A

4:00 Closing Remarks Anthony Heaney, Marvin Bergsneider, Michael Yeh

Page 5: State-of-the-Art Management of Pituitary and Neuroendocrin … · 2010-02-17 · State-of-the-Art Management of Pituitary and Neuroendocrin e 405 Hilgard Avenue Disorders Office of

PITUITARY & NEUROENDOCRINEDISORDERS COURSE Tuition: Physicians $175.00 Nurses $150.00 Fellows/Residents $ 25.00 Please print clearly

___________________________________________________Specialty Degree

___________________________________________________Name (First,Middle,Last)

___________________________________________________Address ___________________________________________________City,State,Zip (|__|__|__|)–|__|__|__|–|__|__|__|__| (|__|__|__|)–|__|__|__|–|__|__|__|__| (Area Code) Business Phone (Area Code) Fax Number

|__|__|__|__|__|__|__|__|__|__|__|__|__|__|__|__|__|__|__|__|__|__|__|__|E-mail Address Last 4 digits of your Social Security Number |__|__|__|__|

Course Enrollment Options q Check enclosed, payable to: Academic Event Management

q Please charge my credit card|__|__|__|__|__|__|__|__|__|__|__|__|__|__|__|__| |__|__|/ |__|__| Card Number Exp.Date

Signature __________________________________________

• Mail completed enrollment form to: Academic Event Management 1396 Rancho Lane Thousand Oaks, CA 91362

• Fax enrollment form to: 805-494-1103 • Register by phone: 805-300-9154 • Register by e-mail: [email protected] • Register on-line:http://neuroendocrineconference.com/

REFUNDS: Cancellations must be received in writing by March 2, 2010 and will be subject to a $30 processing fee. No refunds will be given after that date. If for any reason the course must be canceled, discontinued, or rescheduled by the Office of CME, a full refund will be provided.

COURSE# M089-24

Page 6: State-of-the-Art Management of Pituitary and Neuroendocrin … · 2010-02-17 · State-of-the-Art Management of Pituitary and Neuroendocrin e 405 Hilgard Avenue Disorders Office of

COURSE DESCRIPTION This one-and-a-half-day symposium covers key topics in pituitary and neuroendocrine tumors. Distinguished guest and UCLA faculty will provide comprehensive and authoritative lectures discussing current management guidelines, introducing recent advancements, and putting into perspective the latest research in the field. The course content will be applicable to practicing physicians, residents, and ancillary providers (nurse practitioners and physician assistants) caring for patients with pituitary and neuroendocrine tumors. Attendees will have the opportunity to ask questions and discuss cases with the faculty in interactive sessions.

TARGET AUDIENCE Endocrinologists, Internal Medicine Physicians, Neurosurgeons, Endocrine Surgeons, Oncologists, General & Oncologic Surgeons, and Interventional Radiologists.

COURSE OBJECTIVES At the conclusion of this activity, participants should be able to: 1. Describe key advances in the evaluation and management of pituitary, neuroendocrine and endocrine tumors that will affect clinical practice and will determine the direction of research in these fields in the coming years. 2. Review new imaging techniques in pituitary, neuroendocrine and endocrine tumors. 3. Manage the patient with Cushing’s disease and acromegaly. 4. Discuss the role of radiology and pathology in the management of pituitary tumors. 5. Review the advances in surgical and radiosurgical techniques for pituitary tumors. 6. Discuss the laboratory and radiological evaluation of small bowel carcinoids and pancreatic neuroendocrine tumors 7. Identify which patients with IBD to investigate for carcinoid tumors. 8. Recognize importance of early detection of NETs. 9. Assess the clinical impact of new endoscopic modalities for diagnosis of GI neuroendocrine tumors. 10. Identify the patient with metastatic NET disease and understand the role of debulking surgery and liver transplantation. 11. Describe the long-term management of patients with thyroid cancer. 12. Recognize the etiology and management of hyperparathyroidism. 13. Understand recent advances in the management of adrenal tumors.

ACCREDITATION The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this educational activity for a maximum of 10.5 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This CME activity meets the requirements, under California Assembly Bill 1195, continuing education and cultural and linguistic competency.

Disclosure The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is ”truly independent” and free of commercial influence. In addition to independence, the FDA requires that non-promotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program’s participants. In addition, policy of the Accreditation Council for Continuing Medical Education now mandates that the provider adequately manages all identified potential conflicts of interest prior to the program. We at UCLA, fully endorse the letter and spirit of these concepts.

Page 7: State-of-the-Art Management of Pituitary and Neuroendocrin … · 2010-02-17 · State-of-the-Art Management of Pituitary and Neuroendocrin e 405 Hilgard Avenue Disorders Office of

COURSE LOCATIONHotel Casa Del Mar1910 Ocean WaySanta Monica, CA 90405

ACCOMMODATIONSHotel Casa Del Mar1910 Ocean WaySanta Monica, CA 90405 For reservations, call 800-898-6999Mention “UCLA Pituitary Course” to get a special rate of $285 per night plus taxes. Cut-off date for this special rate is April 1, 2010.

Parking is available at the hotel for a reduced price $14 per day$33 per night

Page 8: State-of-the-Art Management of Pituitary and Neuroendocrin … · 2010-02-17 · State-of-the-Art Management of Pituitary and Neuroendocrin e 405 Hilgard Avenue Disorders Office of

State-of-the-Art M

anagement of

Pituitary and

Neuroendocrine

Disorders

Office of C

ontinuing Medical Education

David G

effen School of Medicine at U

CLA

405 Hilgard A

venueBox 956938Los A

ngeles, CA

90095-6938

Presented by:

PresortedFirst C

lass Mail

U.S. Postage Paid Santa A

na, CA

Permit # 61